CNSX:GTIIPharmaceuticals
Green Thumb Industries (CNSX:GTII) Stock Faces Margin Squeeze Despite Buyback Strength
Green Thumb Industries walked into this earnings print with the stock under pressure, down about 4% over the past week and about 16% over three months, and sitting at CA$9.31 at yesterday’s close. The headline from the quarter is clear. Revenue reached about US$307 million while net income came in at roughly US$4.9 million, a much thinner profit than recent quarters, pointing to a profit squeeze rather than a demand problem.
Short term traders are reacting to the margin hit. Longer term...